Bayforest Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$186K Sell
8,450
-13,443
-61% -$234K 0.21% 144
2025
Q4
$258K Buy
21,893
+6,853
+46% +$88K 0.19% 196
2025
Q3
$238K Buy
+15,040
New +$218K 0.11% 340

Other funds holding CC

Bayforest Capital's CC Position: Q1 2026 in Review

Bayforest Capital reduced its Chemours (CC) stake by 61% in Q1 2026, selling an estimated $234K and leaving 8,450 shares worth $186K. The position accounts for 0.21% of the portfolio, ranked #144.

Bayforest Capital first reported a position in CC in Q3 2025 and has held it in 3 quarters since. The position peaked at $258K in Q4 2025. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Bayforest Capital held 8,450 shares of Chemours worth $186K as of Q1 2026.
  • Bayforest Capital sold 13,443 Chemours shares in Q1 2026, an estimated $234K.
  • Chemours made up 0.21% of Bayforest Capital's portfolio in Q1 2026, its #144 holding.
  • Bayforest Capital first reported a position in Chemours in Q3 2025 and has held it in 3 quarters since.
  • Bayforest Capital's Chemours position peaked at $258K in Q4 2025.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.